Clinical Trial

Physical Exercise Augmented CBT for GAD

Study acronym: PEXACOG
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Generalised anxiety disorder (GAD) is a severe and debilitating anxiety disorder that is highly prevalent among older adults. Anxiety and GAD is a well-documented risk factor for the development of other severe conditions such as depression and dementia, and effective treatments are called for. However, recommended treatment for GAD has consistently been found to yield blunted response rates for older adults compared to younger patients. The purpose of this study is to evaluate the effects of exercise-augmented cognitive behaviour therapy for older adults with GAD. Exercise augmented CBT is expected to yield better results than standard CBT in terms of greater reduction of symptoms and increased rates of remission. The investigators will also investigate the effects of treatment on biological, physiological and neuropsychological measures.
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2016-02-18; most recent amendment 2026-04-22.
Status change: Recruiting → Active, Not Recruiting 2022-11-23
Status change: Not Yet Recruiting → Recruiting 2016-05-27
Trial Details
NCT Number NCT02690441
Lead Sponsor Solli Distriktspsykiatriske Senter
Collaborators: University of Bergen, Norwegian University of Science and Technology, University of Oslo, University of California, Berkeley, William Paterson University of New Jersey, Ohio State University
Conditions Generalized Anxiety Disorder
Enrollment 53 participants
Start Date 2016-03
Primary Completion 2023-10 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-04-28